233 related articles for article (PubMed ID: 25844540)
21. Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue.
Radziuviene G; Rasmusson A; Augulis R; Lesciute-Krilaviciene D; Laurinaviciene A; Clim E; Laurinavicius A
Biomed Res Int; 2017; 2017():2321916. PubMed ID: 28752092
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of analytical accuracy of HER2 status in patients with breast cancer: Comparison of HER2 GPA with HER2 IHC and HER2 FISH.
Jensen SG; Thomas PE; Christensen IJ; Balslev E; Hansen A; Høgdall E
APMIS; 2020 Nov; 128(11):573-582. PubMed ID: 32860265
[TBL] [Abstract][Full Text] [Related]
23. Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests.
Bánkfalvi A; Boecker W; Reiner A
Int J Oncol; 2004 Oct; 25(4):929-35. PubMed ID: 15375542
[TBL] [Abstract][Full Text] [Related]
24. Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study.
Franchet C; Filleron T; Cayre A; Mounié E; Penault-Llorca F; Jacquemier J; Macgrogan G; Arnould L; Lacroix-Triki M
Histopathology; 2014 Jan; 64(2):274-83. PubMed ID: 24117939
[TBL] [Abstract][Full Text] [Related]
25. Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique.
Minot DM; Voss J; Rademacher S; Lwin T; Orsulak J; Caron B; Ketterling R; Nassar A; Chen B; Clayton A
Am J Clin Pathol; 2012 Feb; 137(2):270-6. PubMed ID: 22261453
[TBL] [Abstract][Full Text] [Related]
26. Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.
Turashvili G; Leung S; Turbin D; Montgomery K; Gilks B; West R; Carrier M; Huntsman D; Aparicio S
BMC Cancer; 2009 May; 9():165. PubMed ID: 19476653
[TBL] [Abstract][Full Text] [Related]
27. A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study.
Hicks DG; Buscaglia B; Goda H; McMahon L; Natori T; Turner B; Soukiazian A; Okada H; Nakano Y
BMC Cancer; 2018 Dec; 18(1):1266. PubMed ID: 30563489
[TBL] [Abstract][Full Text] [Related]
28. Effects of the change in cutoff values for human epidermal growth factor receptor 2 status by immunohistochemistry and fluorescence in situ hybridization: a study comparing conventional brightfield microscopy, image analysis-assisted microscopy, and interobserver variation.
Atkinson R; Mollerup J; Laenkholm AV; Verardo M; Hawes D; Commins D; Engvad B; Correa A; Ehlers CC; Nielsen KV
Arch Pathol Lab Med; 2011 Aug; 135(8):1010-6. PubMed ID: 21809992
[TBL] [Abstract][Full Text] [Related]
29. Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.
Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
Diagn Pathol; 2013 Feb; 8():17. PubMed ID: 23379971
[TBL] [Abstract][Full Text] [Related]
30. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
Akhdar A; Bronsard M; Lemieux R; Geha S
Ann Pathol; 2011 Dec; 31(6):472-9. PubMed ID: 22172120
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
[TBL] [Abstract][Full Text] [Related]
32. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
[TBL] [Abstract][Full Text] [Related]
33. Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue.
Belgrader P; Tanner SC; Regan JF; Koehler R; Hindson BJ; Brown AS
Clin Chem; 2013 Jun; 59(6):991-4. PubMed ID: 23358413
[TBL] [Abstract][Full Text] [Related]
34. Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.
Micsik T; Kiszler G; Szabó D; Krecsák L; Hegedűs C; Tibor K; Molnár B
Pathol Oncol Res; 2015 Sep; 21(4):1005-11. PubMed ID: 25788005
[TBL] [Abstract][Full Text] [Related]
35. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
Park IH; Kwon Y; Ro JY; Lee KS; Ro J
Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047
[TBL] [Abstract][Full Text] [Related]
36. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
[TBL] [Abstract][Full Text] [Related]
37. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Human Epidermal Growth Factor Receptor 2 (HER2) Gene Status in Human Breast Cancer Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens by Fluorescence In Situ Hybridization (FISH).
Hwang HC; Gown AM
Methods Mol Biol; 2016; 1406():61-70. PubMed ID: 26820945
[TBL] [Abstract][Full Text] [Related]
39. Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.
Yu R; Xuan W; Zhou L; Luo Y; Liu X; Xiong P; Ren X
Exp Mol Pathol; 2018 Jun; 104(3):235-238. PubMed ID: 29715436
[TBL] [Abstract][Full Text] [Related]
40. Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancer.
Nishimura R; Kagawa A; Tamogami S; Kojima K; Satou M; Yamashita N; Teramoto N; Aogi K
Breast Cancer; 2016 Mar; 23(2):211-5. PubMed ID: 25033760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]